Second-look flexible ureteroscopy after RIRS - Holmium Moses

residual stone fragments retrograde intrarenal surgery second-look flexible ureteroscopy

Journal

Journal of medicine and life
ISSN: 1844-3117
Titre abrégé: J Med Life
Pays: Romania
ID NLM: 101477617

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 27 06 2022
accepted: 12 09 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 26 11 2022
Statut: ppublish

Résumé

Retrograde intrarenal surgery (RIRS) is nowadays more and more indicated in pyelocaliceal stones. Holmium and Thulium lasers are the main lasers used. Fragmenting (basketing) or dusting, despite the new technology, still have residual stones (even having 250 microns). This study evaluates second-look flexible ureteroscopy for residual fragments. We analyzed 246 patients (October 2020-March 2022) on which we used Moses Holmium technology (187 cases) in Group 1 and Soltive Laser System (59 cases) in Group 2. The average stone size was 13.1 mm (range 11-29), and the average stone density was 1026 HU (range 870-1752). We used 270 µm for Ho: YAG laser and 150 µm for TFL. For Holmium, we applied energy 0.4J and frequency 80 Hz. For TFL, we applied fine dusting (0.15 J/100 Hz) and dusting (0.5 J/30 Hz). After three months, we practiced the second flexible ureteroscopy. Both groups were compared for completely visual stone-free rates. Stone-free rate at 3 months (second flexible ureteroscopy) was 86.63% (n=162/187) in Group 1 and 96,61% (n=57/59) in Group 2, respectively. The stone-free correlation with the CT preoperative evaluation was 160/187-85.56% for Holmium and 55/59-93.22% for TFL. We found residual stones after the second flexible ureteroscopy in 25 cases after Holmium laser treatment and only in 2 cases after TFL. In all these cases, we finally obtained zero residual stones. The second flexible ureteroscopy could achieve complete residual stone removal and real stone-free status. Despite a slight difference between these two laser technologies, the second look decreases the residual fragments.

Identifiants

pubmed: 36420299
doi: 10.25122/jml-2022-0180
pii: JMedLife-15-1218
pmc: PMC9675293
doi:

Substances chimiques

Holmium W1XX32SQN1
Thulium 8RKC5ATI4P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1218-1223

Informations de copyright

©2022 JOURNAL of MEDICINE and LIFE.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Asian J Urol. 2015 Jul;2(3):133-141
pubmed: 29264133
J Urol. 2017 Aug;198(2):268-273
pubmed: 28286070
Ultrasound Q. 2012 Sep;28(3):227-33
pubmed: 22902840
Medicine (Baltimore). 2020 Oct 23;99(43):e22704
pubmed: 33120764
J Urol. 1989 Mar;141(3 Pt 2):782-9
pubmed: 2645437
Curr Urol Rep. 2021 Oct 8;22(10):50
pubmed: 34622358
J Urol. 2008 Mar;179(3):981-4
pubmed: 18207179
Indian J Urol. 2019 Jan-Mar;35(1):48-53
pubmed: 30692724
Nat Rev Urol. 2015 May;12(5):281-8
pubmed: 25868563
Scand J Urol. 2016 Jun;50(3):216-9
pubmed: 27111193
J Urol. 1999 Apr;161(4):1085-7
pubmed: 10081843
J Endourol. 1995 Jun;9(3):255-8
pubmed: 7550269
J Mater Sci Mater Med. 2009 Dec;20 Suppl 1:S85-92
pubmed: 18568390
Transl Androl Urol. 2012 Mar;1(1):66-70
pubmed: 26816689
Rev Urol. 2020;22(1):17-23
pubmed: 32523467
J Endourol. 2009 Sep;23(9):1395-8
pubmed: 19694527
World J Urol. 2015 Feb;33(2):247-56
pubmed: 25266163
J Urol. 2012 Dec;188(6):2246-51
pubmed: 23083650
Curr Urol Rep. 2018 May 17;19(6):45
pubmed: 29774438
J Clin Med. 2021 Jul 30;10(15):
pubmed: 34362169
Urology. 2011 Oct;78(4):739-43
pubmed: 21664653
Asian J Urol. 2020 Apr;7(2):110-115
pubmed: 32257803
Curr Opin Urol. 2020 Mar;30(2):144-148
pubmed: 31895890
Kidney Int. 2013 Jan;83(1):146-52
pubmed: 22992468
J Urol. 2013 Jan;189(1):158-64
pubmed: 23164393
Lancet. 2006 Jan 28;367(9507):333-44
pubmed: 16443041
J Endourol. 2018 Oct;32(10):973-977
pubmed: 30039712
J Endourol. 2014 Feb;28(2):131-9
pubmed: 24147820
Nat Rev Urol. 2018 Sep;15(9):563-573
pubmed: 29884804
Urolithiasis. 2019 Jun;47(3):273-278
pubmed: 29484468
Curr Urol Rep. 2017 Apr;18(4):32
pubmed: 28271355
World J Urol. 2021 Jan;39(1):187-194
pubmed: 32270283
Rev Urol. 2015;17(3):160-4
pubmed: 26543430
J Med Life. 2021 May-Jun;14(3):316-322
pubmed: 34377196
World J Urol. 2017 Apr;35(4):675-681
pubmed: 27492012
Eur Urol. 2022 Jul;82(1):73-79
pubmed: 35300888
World J Urol. 2020 Aug;38(8):1883-1894
pubmed: 30729311
J Urol. 2016 Oct;196(4):1161-9
pubmed: 27238615

Auteurs

Bogdan Geavlete (B)

Department of Urology, Sanador Hospital, Bucharest, Romania.
Department of Urology, Sf. Ioan Emergency Clinical Hospital, Bucharest, Romania.

Cristian Mareș (C)

Department of Urology, Sf. Ioan Emergency Clinical Hospital, Bucharest, Romania.

Răzvan Mulțescu (R)

Department of Urology, Sanador Hospital, Bucharest, Romania.
Department of Urology, Sf. Ioan Emergency Clinical Hospital, Bucharest, Romania.

Dragoș Georgescu (D)

Department of Urology, Sanador Hospital, Bucharest, Romania.
Department of Urology, Sf. Ioan Emergency Clinical Hospital, Bucharest, Romania.

Petrișor Geavlete (P)

Department of Urology, Sanador Hospital, Bucharest, Romania.
Department of Urology, Sf. Ioan Emergency Clinical Hospital, Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH